Ling Cheng - Dept Clin Pharmacol & Pharmacometr, AbbVie Inc

基本信息

浏览量：0

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 11 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Risankizumab for Ulcerative Colitis: Two Randomized Clinical Trials

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2024)

引用0浏览0WOS引用

Su1792 EFFICACY OUTCOMES OF PLACEBO MAINTENANCE TREATMENT IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS WHO RESPONDED TO PLACEBO INDUCTION THERAPY: RESULTS FROM THE PHASE 3 COMMAND STUDY

Raja Atreya,Marc Ferrante,Anita Afzali, Giorgos Bamias,Millie D. Long,Ezequiel Neimark,Phillip Levine,Ling Cheng,Jasmina Kalabic,Patrick Hecht,Ramona C. Vladea, Stefan Schreiber

Gastroenterologyno. 5 (2024): S-815-S-816

引用0浏览0引用

Risankizumab Maintenance Therapy in Patients with Moderately to Severely Active Ulcerative Colitis: Efficacy and Safety in the Randomised Phase 3 COMMAND Study

E. Louis,R. Panaccione,G. Parkes, L. Peyrin-Biroulet,M. Ferrante,T. Hisamatsu,B. Siegmund,J. Kalabic,P. Levine,E. Neimark,K. Wallace, S. Chen,L. Cheng,W. R. Duan,A. Armuzzi, L. Biederman,E. Loftus,G. Melmed, S. Schreiber

JOURNAL OF CROHNS & COLITIS (2024): I10-I12

引用0浏览0引用

S1472 Efficacy of Risankizumab Maintenance Therapy by Clinical Remission and Endoscopic Improvement Status in Patients with Moderately to Severely Active Ulcerative Colitis: Post Hoc Analysis of the COMMAND Phase 3 Study

Remo Panaccione,Peter Bossuyt,Irina Blumenstein,Luc Biedermann,Joana Torres, Ramona Vladea,Ling Cheng, Yafei Zhang,Jasmina Kalabic, Karen Chien, Pierre Morisset,Gareth Parkes

American Journal of Gastroenterologyno. 10S (2024)

引用0浏览0引用

904 ADDITIONAL RISANKIZUMAB THERAPY IS EFFECTIVE IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS WHO DID NOT ACHIEVE CLINICAL RESPONSE TO INITIAL 12-WEEK INDUCTION THERAPY: AN ANALYSIS OF PHASE 3 INSPIRE AND COMMAND STUDIES

Remo Panaccione,Gil Melmed,David Drobne,Manreet Kaur,Silvio Danese,Tadakazu Hisamatsu,Phillip Levine,Ezequiel Neimark, Su Chen,Ling Cheng,W Rachel Duan,Ramona C. Vladea,Patrick Hecht,Edouard Louis

Gastroenterologyno. 5 (2024): S-217

引用0浏览0引用

P593 Efficacy of Risankizumab in Patients with Moderately to Severely Active Ulcerative Colitis by Prior Advanced Therapy Failure and Mechanism of Action: Post Hoc Analysis of the INSPIRE and COMMAND Phase 3 Studies

Remo Panaccione,Édouard Louis,Jean–Frédéric Colombel,Geert DʼHaens,Laurent Peyrin‐Biroulet,M Dubinsky,Ken Takeuchi,Jasmina Kalabic, Philip Levine,Ezequiel Neimark, S Chen,Ling Cheng,W. Rachel Duan,Ramona C. Vladea, P M Hecht,Yuri Sánchez González,Stefanie Schreiber,Marc Ferrante

Journal of Crohn's and colitisno. Supplement_1 (2024): i1153-i1155

引用0浏览0引用

Efficacy and Safety of Upadacitinib or Elsubrutinib Alone or in Combination for Patients with Systemic Lupus Erythematosus: A Phase 2 Randomized Controlled Trial

Joan T. Merrill,Yoshiya Tanaka, David D'Cruz, Karina Vila-Rivera,Daniel Siri,Xiaofeng Zeng,Amit Saxena,Martin Aringer,Kristin M. D'Silva,Ling Cheng,Mohamed-Eslam F. Mohamed, Lucia Siovitz,Sumit Bhatnagar,Marie-Claude Gaudreau,Thao T. Doan,Alan Friedman

ARTHRITIS & RHEUMATOLOGY (2024)

引用0浏览0WOS引用

EFFICACY AND SAFETY OF ABBV-599 HIGH DOSE (ELSUBRUTINIB 60 MG AND UPADACITINIB 30 MG) AND UPADACITINIB MONOTHERAPY FOR THE TREATMENT OF SYSTEMIC LUPUS ERYTHEMATOSUS: A PHASE 2, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL

Joan Merrill,Yoshiya Tanaka, David D'Cruz, Karina Vila-Rivera,Daniel Siri,Xiaofeng Zeng,Kristin D'Silva,Ling Cheng,Thierry Sornasse,Thao Doan, Denise Kruzikas,Alan Friedman

ARTHRITIS & RHEUMATOLOGY（2023）

引用0浏览0引用

Pharmacokinetic Comparability of Risankizumab Formulations in Prefilled Syringe and Auto-injector for Subcutaneous Injection

Hoi-Kei Lon,Ling Cheng,Sai Nudurupati, Ralf Loebbert,Rachel Duan,Jasmina Kalabic,Yinuo Pang

Clinical Therapeutics（2021）

引用4浏览0WOS引用

Pharmacokinetics of Risankizumab in Asian Healthy Subjects and Patients with Moderate to Severe Plaque Psoriasis, Generalized Pustular Psoriasis, and Erythrodermic Psoriasis

Amit Khatri,Doerthe Eckert,Rajneet Oberoi,Ahmed Suleiman,Yinuo Pang,Ling Cheng,Ahmed A. Othman

Journal of clinical pharmacology（2019）

引用26浏览0WOS引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn